Grant: Project Grant
Research Institute of the McGill University Health Centre
$967,725.00
Molecular basis to diet-dependent chromatin dependencies in prostate cancer
FY 2018-19
Summary
Prostate cancer is the most prevalent cancer in men and a leading cause of cancer-related lethality. Consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality but the underlying mechanisms of this association are poorly understood. Considering the pandemic of diet-associated metabolic diseases and obesity, combined with the high frequency of newly diagnosed prostate cancers in developed countries, a thorough understanding of this link is urgent. Using an array of prostate cancer models representing clinically relevant subtypes of the disease, we will investigate how high-fat diet-induced obesity impact the reprograming of prostate cancer tumors and favors the development of a more aggressive disease. The overreaching goal is to identify and drug the Achilles heel of this diet-dependent tumor reprograming in order to impede prostate cancer progression and improve treatment options.
Department
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
390144
Name
Labbé David
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics 2
Projecttitle
Molecular basis to diet-dependent chromatin dependencies in prostate cancer
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$967,725
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer Biology; Chromatin; Crispr/Cas9 Ko Screens; Diet; Epigenetics; Mouse Models; Prostate Cancer
Abstract
Prostate cancer is the most prevalent cancer in men and a leading cause of cancer-related lethality. Consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality but the underlying mechanisms of this association are poorly understood. Considering the pandemic of diet-associated metabolic diseases and obesity, combined with the high frequency of newly diagnosed prostate cancers in developed countries, a thorough understanding of this link is urgent. Using an array of prostate cancer models representing clinically relevant subtypes of the disease, we will investigate how high-fat diet-induced obesity impact the reprograming of prostate cancer tumors and favors the development of a more aggressive disease. The overreaching goal is to identify and drug the Achilles heel of this diet-dependent tumor reprograming in order to impede prostate cancer progression and improve treatment options.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Labbé, David
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $967,725~ $0~